These results indicate that SAA suppresses the accumulation and functional differentiation of Cd8+ and Cd4+ effector T cells within the tumor microenvironment, further supporting the immunosuppressive role of SAA as well as the clinical potential of α-SAA in vivo. The gene discussed is SAA1; the disease is neoplasm.